Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Argenx Raises $750m in Gross Proceeds in a Global Offering (2020-05-28)
Regulated information — Inside information argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, announced toda...
Rentschler Extends Collaboration with Genmab to US Facility (2020-05-27)
- Innovative agreement provides flexible model to address Genmab's development and manufacturing needs as programs advance in development - Rentschler Biopharma's U.S. site expansion progressing on track with plans to significantly increase square footage and nu...
Symrise Opens New €50m Production Site in China (2020-05-27)
On May 18, 2020, Symrise experienced a premiere in a number of ways. The company opened its biggest individual investment and invested € 50 million in the construction of the new production site for flavorings and fragrances in Nantong. In addition, the Executive B...
Merck to Acquire Themis Bioscience for Undisclosed Sum (2020-05-26)
Merck to Apply its Industry-Leading Vaccine Development Capabilities to SARS-CoV-2 Vaccine Program Originated by Themis and Institut Pasteur Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Themis, a company focused on vaccines and imm...
Tollys Closes €2.3m Series A Financing Round (2020-05-26)
> Funds will further development of a new cancer immunotherapy: synthetic TLR3 agonist TL-532 > Three senior industry executives join the board of directors Tollys, the developer of TL-532, the first synthetic specific agonist of Toll-like receptor 3 (...
Spindiag Raises €16.3m Series B Financing Round (2020-05-26)
> Financing round successfully closed with participation from existing and new investors > Innovative, PCR-based, SARS-CoV-2 rapid test for point-of-care settings > “Mini-laboratory” provides test results in 30 to 40 minutes > Market launch in Germany and ...
Sterna Biologicals Secures €12m in Private Placement (2020-05-26)
> Proceeds to fund next Phase 2 clinical study with SB010 in moderate to severe asthma and oral formulation work for SB012 in ulcerative colitis > Sterna's approach to down-regulate master transcription factor GATA-3 using a DNAzyme (enzymatic antisense oligonuc...
Proteomedix: Maurizio Ballerini VP Market Development EMEA (2020-05-26)
Proteomedix, the Swiss cancer diagnostics company is pleased to announce the appointment of Dr Maurizio Ballerini, MD as VP Market Development EMEA and Dr Helene Peyro Saint-Paul, MD, as Medical Advisor effective June 1, 2020. These accomplished executives bring a ...
Argenx: Efgartigimod Meets Endpoint in Phase 3 in MG (2020-05-26)
> Trial met primary endpoint (p ?0.0001) > Well-tolerated; safety profile comparable to placebo > Biologics License Application on track to be submitted to U.S. Food and Drug Administration by end of 2020 > Conference call scheduled for today, May 26, 202...
Argenx Launches Proposed $500m Global Offering (2020-05-26)
Regulated information — Inside information argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, announced today ...

» Show all News!

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

» Start here with the latest News!

Picture [iito] – Putting Information into Context 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]